Holdenrieder S - Search Results

1

Serum microRNAs as biomarkers in patients undergoing prostate biopsy: results from a prospective multi-center study.

Westermann AM, Schmidt D, Holdenrieder S, Moritz R, Semjonow A, Schmidt M, Kristiansen G, Müller SC, Ellinger J. Westermann AM, et al. Among authors: holdenrieder s. Anticancer Res. 2014 Feb;34(2):665-9. Anticancer Res. 2014. PMID: 24510997

2

[Detection of cell-free lncRNA in serum of cancer patients].

Kohls K, Schmidt D, Holdenrieder S, Müller SC, Ellinger J. Kohls K, et al. Among authors: holdenrieder s. Urologe A. 2015 Jun;54(6):819-25. doi: 10.1007/s00120-014-3655-5. Urologe A. 2015. PMID: 25312755 German.

3

Circulating serum miRNA (miR-367-3p, miR-371a-3p, miR-372-3p and miR-373-3p) as biomarkers in patients with testicular germ cell cancer.

Syring I, Bartels J, Holdenrieder S, Kristiansen G, Müller SC, Ellinger J. Syring I, et al. Among authors: holdenrieder s. J Urol. 2015 Jan;193(1):331-7. doi: 10.1016/j.juro.2014.07.010. Epub 2014 Jul 18. J Urol. 2015. PMID: 25046619

4

Analysis of tissue and serum microRNA expression in patients with upper urinary tract urothelial cancer.

Kriebel S, Schmidt D, Holdenrieder S, Goltz D, Kristiansen G, Moritz R, Fisang C, Müller SC, Ellinger J. Kriebel S, et al. Among authors: holdenrieder s. PLoS One. 2015 Jan 28;10(1):e0117284. doi: 10.1371/journal.pone.0117284. eCollection 2015. PLoS One. 2015. PMID: 25629698 Free PMC article.

5

Analysis of serum microRNAs (miR-26a-2*, miR-191, miR-337-3p and miR-378) as potential biomarkers in renal cell carcinoma.

Hauser S, Wulfken LM, Holdenrieder S, Moritz R, Ohlmann CH, Jung V, Becker F, Herrmann E, Walgenbach-Brünagel G, von Ruecker A, Müller SC, Ellinger J. Hauser S, et al. Among authors: holdenrieder s. Cancer Epidemiol. 2012 Aug;36(4):391-4. doi: 10.1016/j.canep.2012.04.001. Epub 2012 Apr 26. Cancer Epidemiol. 2012. PMID: 22542158

6

Evaluation of reference genes for the analysis of serum miRNA in patients with prostate cancer, bladder cancer and renal cell carcinoma.

Sanders I, Holdenrieder S, Walgenbach-Brünagel G, von Ruecker A, Kristiansen G, Müller SC, Ellinger J. Sanders I, et al. Among authors: holdenrieder s. Int J Urol. 2012 Nov;19(11):1017-25. doi: 10.1111/j.1442-2042.2012.03082.x. Epub 2012 Jul 12. Int J Urol. 2012. PMID: 22788411

7

Circulating microRNAs in serum: novel biomarkers for patients with bladder cancer?

Scheffer AR, Holdenrieder S, Kristiansen G, von Ruecker A, Müller SC, Ellinger J. Scheffer AR, et al. Among authors: holdenrieder s. World J Urol. 2014 Apr;32(2):353-8. doi: 10.1007/s00345-012-1010-2. Epub 2012 Dec 25. World J Urol. 2014. PMID: 23266581

8

MicroRNAs in renal cell carcinoma: diagnostic implications of serum miR-1233 levels.

Wulfken LM, Moritz R, Ohlmann C, Holdenrieder S, Jung V, Becker F, Herrmann E, Walgenbach-Brünagel G, von Ruecker A, Müller SC, Ellinger J. Wulfken LM, et al. Among authors: holdenrieder s. PLoS One. 2011;6(9):e25787. doi: 10.1371/journal.pone.0025787. Epub 2011 Sep 30. PLoS One. 2011. PMID: 21984948 Free PMC article.

9

Evaluation of Serum Biomarkers (FGF-2, HGF, MIF and PTN) in Patients With Testicular Germ Cell Cancer.

Hauser S, Kaminski A, Syring I, Holdenrieder S, Dieckmann KP, Muller SC, Ellinger J. Hauser S, et al. Among authors: holdenrieder s. In Vivo. 2019 Nov-Dec;33(6):1935-1940. doi: 10.21873/invivo.11688. In Vivo. 2019. PMID: 31662522 Free PMC article.

10

Cytokeratin serum biomarkers in patients with colorectal cancer.

Holdenrieder S, Stieber P, Liska V, Treska V, Topolcan O, Dreslerova J, Matejka VM, Finek J, Holubec L. Holdenrieder S, et al. Anticancer Res. 2012 May;32(5):1971-6. Anticancer Res. 2012. PMID: 22593474

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

281 results

Search Page

Filters